SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019056-20-000553
Filing Date
2020-11-09
Accepted
2020-11-09 06:05:29
Documents
4
Period of Report
2020-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aptevo8k_1106.htm 8-K 57176
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 48414
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 436605
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 11321
  Complete submission text file 0001019056-20-000553.txt   554833
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 201295966
SIC: 2834 Pharmaceutical Preparations